These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38782946)

  • 1. Semaglutide ameliorates pressure overload-induced cardiac hypertrophy by improving cardiac mitophagy to suppress the activation of NLRP3 inflammasome.
    He W; Wei J; Liu X; Zhang Z; Huang R; Jiang Z
    Sci Rep; 2024 May; 14(1):11824. PubMed ID: 38782946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective Inhibition of NLRP3 Inflammasome Reverses Pressure Overload-Induced Pathological Cardiac Remodeling by Attenuating Hypertrophy, Fibrosis, and Inflammation.
    Zhao M; Zhang J; Xu Y; Liu J; Ye J; Wang Z; Ye D; Feng Y; Xu S; Pan W; Wang M; Wan J
    Int Immunopharmacol; 2021 Oct; 99():108046. PubMed ID: 34435581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semaglutide attenuates seizure severity and ameliorates cognitive dysfunction by blocking the NLR family pyrin domain containing 3 inflammasome in pentylenetetrazole‑kindled mice.
    Wang L; Ding J; Zhu C; Guo B; Yang W; He W; Li X; Wang Y; Li W; Wang F; Sun T
    Int J Mol Med; 2021 Dec; 48(6):. PubMed ID: 34676876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NLRP3 Inflammasome Activation Through Heart-Brain Interaction Initiates Cardiac Inflammation and Hypertrophy During Pressure Overload.
    Higashikuni Y; Liu W; Numata G; Tanaka K; Fukuda D; Tanaka Y; Hirata Y; Imamura T; Takimoto E; Komuro I; Sata M
    Circulation; 2023 Jan; 147(4):338-355. PubMed ID: 36440584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotinamide Riboside Alleviates Cardiac Dysfunction and Remodeling in Pressure Overload Cardiac Hypertrophy.
    Ma S; Feng J; Lin X; Liu J; Tang Y; Nie S; Gong J; Wang L
    Oxid Med Cell Longev; 2021; 2021():5546867. PubMed ID: 34567409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Anti-Inflammatory Mediator 17(R)-Resolvin D1 Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis.
    Wang M; Pan W; Wei C; Liu J; Zhang J; Yu J; Zhao M; Xu S; Ye J; Wang Z; Ye D; Feng Y; Xu Y; Wan J
    Drug Des Devel Ther; 2023; 17():3073-3083. PubMed ID: 37849783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular mechanism of MiR-26a-5p regulates autophagy and activates NLRP3 inflammasome to mediate cardiomyocyte hypertrophy.
    Tang LQ; Wang W; Tang QF; Wang LL
    BMC Cardiovasc Disord; 2024 Jan; 24(1):18. PubMed ID: 38172711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkin-Dependent Mitophagy is Required for the Inhibition of ATF4 on NLRP3 Inflammasome Activation in Cerebral Ischemia-Reperfusion Injury in Rats.
    He Q; Li Z; Meng C; Wu J; Zhao Y; Zhao J
    Cells; 2019 Aug; 8(8):. PubMed ID: 31416289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin-mediated mitophagy protects against early brain injury after subarachnoid hemorrhage through inhibition of NLRP3 inflammasome activation.
    Cao S; Shrestha S; Li J; Yu X; Chen J; Yan F; Ying G; Gu C; Wang L; Chen G
    Sci Rep; 2017 May; 7(1):2417. PubMed ID: 28546552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca
    Suetomi T; Willeford A; Brand CS; Cho Y; Ross RS; Miyamoto S; Brown JH
    Circulation; 2018 Nov; 138(22):2530-2544. PubMed ID: 30571348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of Sacubitril/Valsartan against Pathological Cardiac Remodeling by Inhibiting the NLRP3 Inflammasome after Relief of Pressure Overload in Mice.
    Li X; Zhu Q; Wang Q; Zhang Q; Zheng Y; Wang L; Jin Q
    Cardiovasc Drugs Ther; 2020 Oct; 34(5):629-640. PubMed ID: 32444995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SNO-MLP (S-Nitrosylation of Muscle LIM Protein) Facilitates Myocardial Hypertrophy Through TLR3 (Toll-Like Receptor 3)-Mediated RIP3 (Receptor-Interacting Protein Kinase 3) and NLRP3 (NOD-Like Receptor Pyrin Domain Containing 3) Inflammasome Activation.
    Tang X; Pan L; Zhao S; Dai F; Chao M; Jiang H; Li X; Lin Z; Huang Z; Meng G; Wang C; Chen C; Liu J; Wang X; Ferro A; Wang H; Chen H; Gao Y; Lu Q; Xie L; Han Y; Ji Y
    Circulation; 2020 Mar; 141(12):984-1000. PubMed ID: 31902237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Berberine suppresses influenza virus-triggered NLRP3 inflammasome activation in macrophages by inducing mitophagy and decreasing mitochondrial ROS.
    Liu H; You L; Wu J; Zhao M; Guo R; Zhang H; Su R; Mao Q; Deng D; Hao Y
    J Leukoc Biol; 2020 Jul; 108(1):253-266. PubMed ID: 32272506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RyR2 Stabilizer Attenuates Cardiac Hypertrophy by Downregulating TNF-α/NF-κB/NLRP3 Signaling Pathway through Inhibiting Calcineurin.
    Gao Y; Li S; Liu X; Si D; Chen W; Yang F; Sun H; Yang P
    J Cardiovasc Transl Res; 2024 Jun; 17(3):481-495. PubMed ID: 38652413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
    Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
    Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triptolide attenuates pressure overload-induced myocardial remodeling in mice via the inhibition of NLRP3 inflammasome expression.
    Li R; Lu K; Wang Y; Chen M; Zhang F; Shen H; Yao D; Gong K; Zhang Z
    Biochem Biophys Res Commun; 2017 Mar; 485(1):69-75. PubMed ID: 28202417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Honokiol-Mediated Mitophagy Ameliorates Postoperative Cognitive Impairment Induced by Surgery/Sevoflurane via Inhibiting the Activation of NLRP3 Inflammasome in the Hippocampus.
    Ye JS; Chen L; Lu YY; Lei SQ; Peng M; Xia ZY
    Oxid Med Cell Longev; 2019; 2019():8639618. PubMed ID: 30918581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload.
    Zhou N; Ma B; Stoll S; Hays TT; Qiu H
    Aging Cell; 2017 Oct; 16(5):1168-1179. PubMed ID: 28799247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload.
    Beetz N; Rommel C; Schnick T; Neumann E; Lother A; Monroy-Ordonez EB; Zeeb M; Preissl S; Gilsbach R; Melchior-Becker A; Rylski B; Stoll M; Schaefer L; Beyersdorf F; Stiller B; Hein L
    J Mol Cell Cardiol; 2016 Dec; 101():145-155. PubMed ID: 27789290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liraglutide ameliorates non-alcoholic steatohepatitis by inhibiting NLRP3 inflammasome and pyroptosis activation via mitophagy.
    Yu X; Hao M; Liu Y; Ma X; Lin W; Xu Q; Zhou H; Shao N; Kuang H
    Eur J Pharmacol; 2019 Dec; 864():172715. PubMed ID: 31593687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.